Cx Institutional’s Eli Lilly & Co Position
Does Cx Institutional own Eli Lilly & Co (LLY)? Yes — 35.5K shares worth $43M (+1.23% of its 13F portfolio) as of Q2 2026, up from 33.8K shares the prior filed quarter.
Position Value
$43M
Q2 2026
Shares
35.5K
% of Portfolio
+1.23%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 35.5K | $43M | +1.23% |
| Q1 2026 | 33.8K | $31M | +0.95% |
| Q4 2025 | 29.3K | $31M | +0.94% |
| Q3 2025 | 30.9K | $24M | +0.72% |
| Q2 2025 | 28.7K | $22M | +0.78% |
| Q1 2025 | 27.2K | $22M | +0.85% |
| Q4 2024 | 23.6K | $18M | +0.72% |
| Q3 2024 | 19.2K | $17M | +0.75% |
| Q2 2024 | 19.6K | $18M | +0.83% |
| Q1 2024 | 20.5K | $16M | +0.77% |
| Q4 2023 | 19.1K | $11M | +0.60% |
| Q3 2023 | 22.0K | $12M | +0.65% |
| Q2 2023 | 30.3K | $14M | +0.74% |
| Q1 2023 | 30.3K | $11M | +0.56% |
| Q4 2022 | 16.2K | $6M | +0.36% |
| Q3 2022 | 6.1K | $2M | +0.14% |
| Q2 2022 | 5.4K | $2M | +0.13% |
| Q1 2022 | 4.7K | $1M | +0.11% |
| Q4 2021 | 4.3K | $1M | +0.09% |
| Q3 2021 | 4.2K | $979,000 | +0.08% |
| Q2 2021 | 4.3K | $982,000 | +0.08% |
| Q1 2021 | 14.1K | $3M | +0.24% |
| Q4 2020 | 10.7K | $2M | +0.17% |
| Q3 2020 | 11.8K | $2M | +0.19% |
| Q2 2020 | 11.2K | $2M | +0.24% |
| Q1 2020 | 10.9K | $2M | +0.25% |
| Q4 2019 | 2.6K | $345,000 | +0.06% |
| Q3 2019 | 2.7K | $298,000 | +0.05% |
| Q2 2019 | 4.0K | $441,000 | +0.07% |
| Q1 2019 | 3.6K | $462,000 | +0.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cx Institutional’s full portfolio or all institutional holders of LLY.